Teva Pharmaceutical Industries (TEVA) Stock Research, Analysis & News

Quick Analysis on Teva Pharmaceutical Industries (TEVA) Stock as of August 21, 2019

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Teva Pharmaceutical Industries (TEVA) Stock below)

Teva Pharmaceutical Industries (TEVA) Stock Profile Summary

Teva Pharmaceutical Industries Limited engages in the development, production, and sale of a range of generic and branded pharmaceuticals, biogenerics, and active pharmaceutical ingredients (APIs) worldwide. The companys principal products include Copaxone for multiple sclerosis; and Azilect for Parkinsons disease. Teva Pharmaceutical also provides specialty pharmaceutical products, which include respiratory products based on its proprietary delivery systems, including Easi-Breathe, an advanced breath-activated inhaler; Spiromax/Airmax, a multidose dry powder inhaler; Steri-Nebs, the blow-fill-seal based nebulizers; and Cyclohaler, a single dose dry powder device. The companys branded respiratory products include ProAir, a short-acting beta-agonist for the treatment of bronchial spasms and exercise-induced bronchospasm; and Qvar, an inhaled corticosteroid for long-term control of chronic bronchial asthma. In addition, it offers APIs for respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company provides womens health care products, such as oral contraceptives, intrauterine contraception, and hormone therapy treatments for menopause/perimenopause, as well as therapies for use in infertility and urinary incontinence. It also holds a biotechnology platform focused on the development of peptide and protein-based medicines. Teva Pharmaceutical has cooperation agreements with Kowa Company, Ltd.; Lonza Group Ltd.; H. Lundbeck A/S; Impax Laboratories, Inc.; Anchen Pharmaceuticals, Inc.; sanofi-aventis; OncoGenex Pharmaceuticals; MediWound Ltd.; and Polyheal Ltd. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Teva Pharmaceutical Industries (TEVA) Stock Key Statistics Research and Analysis as of August 21, 2019

Teva Pharmaceutical Industries (TEVA) Stock Competitor Research and Analysis

Watson Pharmaceuticals Inc. (WPI)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Life Technologies Corporation (LIFE)
King Pharmaceuticals Inc. (KG)Mylan, Inc. (MYL)
Pfizer Inc. (PFE)Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)Sanofi-Aventis (SNY)
Novartis AG (NVS)AstraZeneca PLC (AZN)

Mutual Funds with Teva Pharmaceutical Industries (TEVA) Stock in its top 10 holdings

FundCategoryTEVA Holding Percentage
American Beacon Intl Equity InstlForeign Large Value1.28%
AllianzGI NFJ International Value CForeign Large Value2.88%
Invesco Global Growth CWorld Stock1.87%
AllianzGI NFJ International Value AForeign Large Value2.88%
Invesco Global Growth AWorld Stock1.87%
American Beacon Intl Equity AForeign Large Value1.28%
Invesco International Growth BForeign Large Growth2.46%

Stock Research on Teva Pharmaceutical Industries (TEVA)

Latest Market News on Teva Pharmaceutical Industries (TEVA)


Click here to find the latest news on Teva Pharmaceutical Industries (TEVA)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Watson Pharmaceuticals Inc. (WPI)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)